Effect of the revision on the Condensed Consolidated Financial Statements for the three and nine months ended September 30, 2023 (Tables)

9 Months Ended

Sep. 30, 2024

Effect of the revision on the Condensed Consolidated Financial Statements for the three and nine months ended September 30, 2023

Schedule of effect of restatement of financial statements

CONDENSED CONSOLIDATED STATEMENT OF LOSS AND OTHER COMPREHENSIVE INCOME (UNAUDITED)

	Three months ended September 30, 2023			Nine months ended September 30, 2023
	As previously reported	Adjustments	Revised	As previously reported	Adjustments	Revised
	$’000	$’000	$’000	$’000	$’000	$’000
Cost of sales	(365,032)	6,149	(358,883)	(949,774)	(12,854)	(962,628)
Operating income	7,478	6,149	13,627	369,248	(12,854)	356,394
Finance costs	(261,993)	(9,602)	(271,595)	(1,804,222)	(12,642)	(1,816,864)
Loss before income tax	(248,692)	(3,453)	(252,145)	(1,416,741)	(25,496)	(1,442,237)
Loss for the period	(265,351)	(3,453)	(268,804)	(1,505,859)	(25,496)	(1,531,355)
Loss attributable to:
Owners of the Company	(263,377)	(3,453)	(266,830)	(1,497,525)	(25,496)	(1,523,021)
Loss for the period	(265,351)	(3,453)	(268,804)	(1,505,859)	(25,496)	(1,531,355)
Loss per share - basic	(0.79)	(0.01)	(0.80)	(4.49)	(0.08)	(4.57)
Loss per share - diluted	(0.79)	(0.01)	(0.80)	(4.49)	(0.08)	(4.57)
Other comprehensive income:
Exchange differences on translation of foreign operations	4,789	557	5,346	629,755	5,047	634,802
Other comprehensive income for the period, net of taxes	4,789	557	5,346	629,755	5,047	634,802
Total comprehensive loss for the period	(260,562)	(2,896)	(263,458)	(876,104)	(20,449)	(896,553)
Total comprehensive loss attributable to:
Owners of the Company	(251,373)	(2,896)	(254,269)	(876,163)	(20,449)	(896,612)
Total comprehensive loss for the period	(260,562)	(2,896)	(263,458)	(876,104)	(20,449)	(896,553)

CONDENSED CONSOLIDATED STATEMENT OF CHANGES IN EQUITY (UNAUDITED)

	As previously reported		Adjustments		Revised
	Accumulated	Other	Accumulated	Other	Accumulated	Other
	losses	reserves	losses	reserves	losses	reserves
	$’000	$’000	$’000	$’000	$’000	$’000
Balance at January 1, 2023	(3,317,652)	(861,271)	—	—	(3,317,652)	(861,271)
Loss for the period	(1,497,525)	—	(25,496)	—	(1,523,021)	—
Other comprehensive income	—	621,362	—	5,047	—	626,409
Total comprehensive (loss)/income	(1,497,525)	621,362	(25,496)	5,047	(1,523,021)	626,409
Balance at September 30, 2023	(4,814,310)	(321,440)	(25,496)	5,047	(4,839,806)	(316,393)

CONDENSED CONSOLIDATED STATEMENT OF CASH FLOWS (UNAUDITED)

	Three months ended September 30, 2023			Nine months ended September 30, 2023
	As previously reported	Adjustments	Revised	As previously reported	Adjustments	Revised
	$’000	$’000	$’000	$’000	$’000	$’000
Cash flows from operating activities
Cash from operations	234,437	(4,524)	229,913	750,428	(9,559)	740,869
Net cash generated from/(used in) operating activities	224,777	(4,524)	220,253	703,547	(9,559)	693,988
Cash flow from investing activities
Purchase of property, plant and equipment	(124,413)	4,524	(119,889)	(393,015)	9,559	(383,456)
Net cash (used in)/generated from investing activities	(188,129)	4,524	(183,605)	(638,282)	9,559	(628,723)
Net cash used in financing activities	(29,115)	—	(29,115)	(11,806)	—	(11,806)
Cash and cash equivalents at end of period	425,436	—	425,436	425,436	—	425,436